| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a6ef945d903469ec0a856bea30fdae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cc87d476fde0ce82ac3b7245e61b785 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-634 |
| filingDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b667bac0f195cf0257a18e3775f32e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dc9b46aefb8a3622e593b86dfda1732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3bc86f0728955d5ad08500741986291 |
| publicationDate |
2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018008898-A |
| titleOfInvention |
Anticancer agent, radiosensitizer and food composition |
| abstract |
PROBLEM TO BE SOLVED: To provide an anticancer agent, a radiosensitizer and a food composition capable of enhancing the effect of radiotherapy. [MEANS FOR SOLVING PROBLEMS] The inventors of the present invention have found that mice treated with human pancreatic cancer cells were treated with gobovine extract containing arctigenin in combination with radiotherapy, and compared with the untreated group and each monotherapy group, the tumor significantly increased. Found to shrink. The anticancer agent of the present invention is an anticancer agent for use in combination with radiotherapy, containing arctigenin and / or arctiin as an active ingredient. You may contain as. [Selection] Figure 1 |
| priorityDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |